Literature DB >> 29371324

Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation.

Shigeo Fuji1,2, Atae Utsunomiya3, Yoshitaka Inoue4, Takashi Miyagi5, Satsuki Owatari6, Yasushi Sawayama7, Yukiyoshi Moriuchi8, Ilseung Choi9, Takero Shindo10, Shin-Ichiro Yoshida11, Satoshi Yamasaki12, Takuhiro Yamaguchi13, Takahiro Fukuda14.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29371324      PMCID： PMC5927966          DOI： 10.3324/haematol.2017.184564

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.

Authors:  Takashi Ishida; Tatsuro Joh; Naokuni Uike; Kazuhito Yamamoto; Atae Utsunomiya; Shinichiro Yoshida; Yoshio Saburi; Toshihiro Miyamoto; Shigeki Takemoto; Hitoshi Suzushima; Kunihiro Tsukasaki; Kisato Nosaka; Hiroshi Fujiwara; Kenji Ishitsuka; Hiroshi Inagaki; Michinori Ogura; Shiro Akinaga; Masao Tomonaga; Kensei Tobinai; Ryuzo Ueda
Journal:  J Clin Oncol       Date:  2012-02-06       Impact factor: 44.544

2.  Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.

Authors:  H Fujiwara; S Fuji; A Wake; K Kato; Y Takatsuka; T Fukuda; J Taguchi; N Uchida; T Miyamoto; M Hidaka; Y Miyazaki; T Tomoyose; M Onizuka; M Takanashi; T Ichinohe; Y Atsuta; A Utsunomiya
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

3.  Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP.

Authors:  A Bazarbachi; K Cwynarski; A Boumendil; H Finel; P Fields; K Raj; A Nagler; M Mohty; A Sureda; P Dreger; O Hermine
Journal:  Bone Marrow Transplant       Date:  2014-07-14       Impact factor: 5.483

4.  The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.

Authors:  Dai Chihara; Michelle A Fanale; Roberto N Miranda; Mansoor Noorani; Jason R Westin; Loretta J Nastoupil; Fredrick B Hagemeister; Luis E Fayad; Jorge E Romaguera; Felipe Samaniego; Francesco Turturro; Hun J Lee; Sattva S Neelapu; M Alma Rodriguez; Michael Wang; Nathan H Fowler; Richard E Davis; L Jeffrey Medeiros; Chitra Hosing; Yago L Nieto; Yasuhiro Oki
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

5.  Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.

Authors:  Kazuhito Yamamoto; Atae Utsunomiya; Kensei Tobinai; Kunihiro Tsukasaki; Naokuni Uike; Kimiharu Uozumi; Kazunari Yamaguchi; Yasuaki Yamada; Shuichi Hanada; Kazuo Tamura; Shigeo Nakamura; Hiroshi Inagaki; Koichi Ohshima; Hitoshi Kiyoi; Takashi Ishida; Kouji Matsushima; Shiro Akinaga; Michinori Ogura; Masao Tomonaga; Ryuzo Ueda
Journal:  J Clin Oncol       Date:  2010-02-22       Impact factor: 44.544

Review 6.  Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.

Authors:  Shigeo Fuji; Takero Shindo
Journal:  Stem Cell Investig       Date:  2016-10-31

7.  Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.

Authors:  Vivien Mak; Jeremey Hamm; Mukesh Chhanabhai; Tamara Shenkier; Richard Klasa; Laurie H Sehn; Diego Villa; Randy D Gascoyne; Joseph M Connors; Kerry J Savage
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

8.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

9.  Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality.

Authors:  Shigeo Fuji; Yoshitaka Inoue; Atae Utsunomiya; Yukiyoshi Moriuchi; Kaoru Uchimaru; Ilseung Choi; Eiichi Otsuka; Hideho Henzan; Koji Kato; Takeaki Tomoyose; Hisashi Yamamoto; Saiko Kurosawa; Ken-Ichi Matsuoka; Takuhiro Yamaguchi; Takahiro Fukuda
Journal:  J Clin Oncol       Date:  2016-08-09       Impact factor: 44.544

10.  Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation.

Authors:  Shigeo Fuji; Takuhiro Yamaguchi; Yoshitaka Inoue; Atae Utsunomiya; Yukiyoshi Moriuchi; Kaoru Uchimaru; Satsuki Owatari; Takashi Miyagi; Jun Taguchi; Ilseung Choi; Eiichi Otsuka; Sawako Nakachi; Hisashi Yamamoto; Saiko Kurosawa; Kensei Tobinai; Takahiro Fukuda
Journal:  Haematologica       Date:  2017-03-24       Impact factor: 9.941
View more
  10 in total

1.  The functions and prognostic values of chemokine and chemokine receptors in gastric cancer.

Authors:  Chenglong He; Liping He; Qiaowei Lu; Jianjun Xiao; Wenjing Dong
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

2.  Systematic review of survival outcomes for relapsed or refractory adult T-cell leukemia-lymphoma.

Authors:  Kisato Nosaka; Bruce Crawford; Jingbo Yi; William Kuan; Tomoko Matsumoto; Takeshi Takahashi
Journal:  Eur J Haematol       Date:  2021-12-08       Impact factor: 3.674

Review 3.  Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy.

Authors:  Valeria Mollica Poeta; Matteo Massara; Arianna Capucetti; Raffaella Bonecchi
Journal:  Front Immunol       Date:  2019-03-06       Impact factor: 7.561

Review 4.  Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma.

Authors:  Atae Utsunomiya
Journal:  Front Microbiol       Date:  2019-10-01       Impact factor: 5.640

Review 5.  Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions.

Authors:  Agnieszka Dominiak; Beata Chełstowska; Wioletta Olejarz; Grażyna Nowicka
Journal:  Cancers (Basel)       Date:  2020-05-14       Impact factor: 6.639

Review 6.  Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers.

Authors:  Ha Thi Thu Do; Chang Hoon Lee; Jungsook Cho
Journal:  Cancers (Basel)       Date:  2020-01-24       Impact factor: 6.639

7.  Safety and effectiveness of mogamulizumab in relapsed or refractory adult T-cell leukemia-lymphoma.

Authors:  Kenji Ishitsuka; Satoshi Yurimoto; Yukie Tsuji; Manabu Iwabuchi; Takeshi Takahashi; Kensei Tobinai
Journal:  Eur J Haematol       Date:  2019-03-12       Impact factor: 2.997

8.  The Role of CCL20-CCR6 Axis in Ovarian Cancer Metastasis.

Authors:  Wan Liu; Wenjing Wang; Ning Zhang; Wen Di
Journal:  Onco Targets Ther       Date:  2020-12-11       Impact factor: 4.147

Review 9.  The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy.

Authors:  Géraldine Schlecht-Louf; Claire Deback; Françoise Bachelerie
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

10.  Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma.

Authors:  Zihang Ling; Wei Li; Jiaqi Hu; Yuanyuan Li; Miao Deng; Siyuan Zhang; Xianyue Ren; Tong Wu; Juan Xia; Bin Cheng; Xiaoan Tao
Journal:  Cell Death Dis       Date:  2022-02-17       Impact factor: 8.469
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.